Clinical Trial Results: Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for temozolomide in advanced SDH-mutant/deficient gastrointestinal stromal tumors have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumors

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Adam Burgoyne, MD, PhD | Conditions: Gastrointestinal Stromal Tumors, Sdh | Phase 2 | Status: COMPLETED | Results posted: 2026-07-28